A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS

Part of paid clinical trials in Miami, Florida.

Sponsor
Antelope Surgical Solutions, Inc
Study ID
NCT06906471
Phase
PHASE1/PHASE2
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • AS1986NS — DRUG
    Single dose, IV, 100 µg of AS1986NS

Study Details

A Single-Arm, blinded, fluorescent PSMA histopathology trial of AS1986NS

Key Dates

First listed
Apr 2, 2025
Start date
Jul 1, 2026
Status verified
Jul 2026
Primary completion
Oct 30, 2026
Completion
Dec 30, 2026

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Single dose of AS1986NS
    Single dose of AS1986NS administered as an injection through peripheral intravenous access.

Primary Outcome Measure

Safety of AS1986NS [ Time Frame: Enrollment to 30 days post single infusion ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
HCA Florida Kendall HospitalMiamiFlorida33175
Shirin Razdan, MD
[email protected]
305-468-3314
Icahn School of Medicine at Mount Sinai (ISMMS)New YorkNew York10029
Sujit Nair, PhD
[email protected]
212-241-6500
Ashutosh Tewari, MBBS, MCh, FRCS (Hon) (PRINCIPAL_INVESTIGATOR)

Find similar trials in Miami, FL

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
HCA Florida Kendall Hospital· Miami, FLIcahn School of Medicine at Mount Sinai (ISMMS)· New York, NY

Related Studies